Tag: quality management

Oversight of Monitoring, Data Management and Statistical Functions Under GCP Oversight of Monitoring, Data Management and Statistical Functions Under GCP Good Clinical Practice (GCP) guidelines set forth by regulatory authorities such as the FDA, EMA, and MHRA outline the necessary requirements for the conduct of clinical trials. This tutorial serves as a comprehensive guide focused…

Read More “Oversight of Monitoring, Data Management and Statistical Functions Under GCP” »

Sponsor Responsibilities in Decentralized and Platform Trial Models Sponsor Responsibilities in Decentralized and Platform Trial Models Introduction to Decentralized and Platform Trials In the evolving landscape of clinical research, decentralized and platform trial models have gained prominence, offering opportunities to enhance patient engagement, improve efficiency, and broaden the scope of data collection. These novel methodologies…

Read More “Sponsor Responsibilities in Decentralized and Platform Trial Models” »

Risk-Based Quality Management Systems for Sponsors and CROs In the realm of clinical trials, particularly in contexts such as non-small cell lung cancer clinical trials, the implementation of a Risk-Based Quality Management System (RBQM) is essential for ensuring compliance and enhancing the quality of research. This guide provides a comprehensive overview of RBQM systems for…

Read More “Risk-Based Quality Management Systems for Sponsors and CROs” »

GCP Obligations for Safety Management, Pharmacovigilance and Signal Detection GCP Obligations for Safety Management, Pharmacovigilance and Signal Detection Understanding GCP Obligations in Clinical Trials Good Clinical Practice (GCP) serves as an essential foundation for conducting clinical trials across various regions, including the US, UK, and the EU. The obligations outlined by GCP ensure the protection…

Read More “GCP Obligations for Safety Management, Pharmacovigilance and Signal Detection” »

Designing a Sponsor Oversight Model That Meets ICH E6(R3) Expectations Designing a Sponsor Oversight Model That Meets ICH E6(R3) Expectations In the evolving landscape of clinical research, effective oversight by sponsors is essential for ensuring compliance with regulatory guidelines and the successful completion of clinical trials. The ICH E6(R3) guidelines introduce specific expectations for sponsor…

Read More “Designing a Sponsor Oversight Model That Meets ICH E6(R3) Expectations” »

Vendor Qualification, Selection and Management as a GCP Requirement Vendor Qualification, Selection and Management as a GCP Requirement In the context of clinical trials, ensuring that vendors adhere to Good Clinical Practice (GCP) standards is imperative for maintaining compliance and achieving success in research outcomes. This article presents a comprehensive step-by-step guide to effective vendor…

Read More “Vendor Qualification, Selection and Management as a GCP Requirement” »

Sponsor GCP Obligations: Oversight, Quality Management and Risk Control Sponsor GCP Obligations: Oversight, Quality Management and Risk Control Clinical trials are a fundamental part of the drug development process, providing the necessary evidence for regulatory approvals and subsequent market access. The obligations of sponsors under Good Clinical Practice (GCP) ensure the ethical and scientific integrity…

Read More “Sponsor GCP Obligations: Oversight, Quality Management and Risk Control” »

CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains In the realm of clinical trials, the outsourcing of responsibilities to Contract Research Organizations (CROs) has become a prevalent practice amongst sponsors. Nevertheless, while outsourcing is commonplace, it is imperative that sponsors understand the regulatory…

Read More “CRO Responsibilities Under GCP: Where Outsourcing Ends and Accountability Remains” »